NPS Pharmaceuticals (NASDAQ: NPSP), a Bedminster, New Jersey-based orphan drug developer, saw positive results using a hormone replacement therapy drug in a phase 3 clinical trial to treat ...

"We now know that the origins of the comorbidity between depression and endocrine-metabolic conditions differs by condition; non-autoimmune conditions demonstrated shared genetic influences with ...

A new statement describes the importance of extracellular vesicles as a new research target for understanding the causes of certain endocrine disorders such as cancer and diabetes and discovering new ...

MBX Biosciences has filed to raise $100 million in an IPO to advance its clinical-stage programs for endocrine and metabolic disorder treatments, although the final figure may differ. The firm's lead ...

Credit: Getty Images We spoke with endocrinologists to explore the potential of artificial intelligence in the management of chronic disease, including diabetes, obesity, and PCOS. Artificial ...

Polycystic Ovary Syndrome (PCOS) is thought to be the most common endocrine disorder in women, with rates ranging from 7-10 percent of women of childbearing age. In the United States, an estimated 5-6 ...

Women with Hashimoto’s thyroiditis plus a non-endocrine autoimmune disorder were more likely to have multiple miscarriages than those with Hashimoto’s thyroiditis, according to findings published in ...

As the only pituitary-directed therapy, Signifor represents a novel therapeutic approach by addressing the underlying mechanism of Cushing's disease[1] In the Phase III trial, most patients ...

Danish pharmaceutical multinational Novo Nordisk is expanding its presence in inherited blood disorder treatments ...